VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 183 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,435 | +483.6% | 673 | +500.9% | 0.00% | – |
| Q1 2023 | $760 | -81.3% | 112 | -79.6% | 0.00% | -100.0% |
| Q4 2022 | $4,065 | -32.2% | 550 | -14.9% | 0.00% | 0.0% |
| Q3 2022 | $6,000 | -60.0% | 646 | -52.6% | 0.00% | -50.0% |
| Q2 2022 | $15,000 | +87.5% | 1,364 | +101.5% | 0.00% | +100.0% |
| Q1 2022 | $8,000 | -20.0% | 677 | +4.8% | 0.00% | -50.0% |
| Q4 2021 | $10,000 | -9.1% | 646 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $11,000 | -21.4% | 646 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | +40.0% | 646 | 0.0% | 0.00% | +50.0% |
| Q1 2021 | $10,000 | +25.0% | 646 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $8,000 | +33.3% | 646 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $6,000 | 0.0% | 646 | +17.5% | 0.00% | 0.0% |
| Q2 2020 | $6,000 | 0.0% | 550 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,000 | – | 550 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Signpost Capital Advisors, LP | 1,688,952 | $27,327,000 | 10.37% |
| Palo Alto Investors LP | 3,240,424 | $52,430,000 | 3.90% |
| Parametrica Management Ltd | 12,509 | $202,000 | 1.53% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,740,400 | $28,160,000 | 1.08% |
| PACIFIC ALTERNATIVE ASSET MANAGEMENT COMPANY, LLC | 557,100 | $9,014,000 | 1.07% |
| Westend Capital Management, LLC | 64,086 | $841,000 | 1.00% |
| WALL STREET ASSOCIATES | 702,700 | $11,370,000 | 0.98% |
| Baker Brothers Advisors | 4,372,153 | $70,741,000 | 0.87% |
| Iguana Healthcare Management, LLC | 100,000 | $1,618,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,085,301 | $17,560,000 | 0.71% |